Cargando…
Predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients
The Xeroderma pigmentosum complementation group G (XPG) rs2296147T>C polymorphism is suspected to associate with the clinical outcomes of cancer patients. However, the results are inconsistent. This meta-analysis aimed to evaluate the reliable predictive value of XPG rs2296147T>C polymorphism...
Autores principales: | Wang, Yuhan, Han, Yingying, Weng, Qiang, Yuan, Zhengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323191/ https://www.ncbi.nlm.nih.gov/pubmed/27588464 http://dx.doi.org/10.18632/oncotarget.11664 |
Ejemplares similares
-
XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer
por: Wang, Fang, et al.
Publicado: (2016) -
Association of XPG rs2094258 polymorphism with gastric cancer prognosis
por: Wang, Xiao-Qin, et al.
Publicado: (2019) -
XPG gene rs751402 C>T polymorphism and cancer risk: Evidence from 22 publications
por: Zhou, Haixia, et al.
Publicado: (2017) -
XPG rs17655 G>C polymorphism associated with cancer risk: evidence from 60 studies
por: Zhao, Jie, et al.
Publicado: (2018) -
XPG rs873601 G>A contributes to uterine leiomyoma susceptibility in a Southern Chinese population
por: Liu, Zhi-Qin, et al.
Publicado: (2018)